Estimating Survival in Patients With Lung Cancer and Brain Metastases: An Update of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA).

Paul W. Sperduto; T. Jonathan Yang; Kathryn Beal; Hubert Pan; Paul D. Brown; Ananta Bangdiwala; Ryan Shanley; Norman Yeh; Laurie E. Gaspar; Steve Braunstein; Penny Sneed; John Boyle; John P. Kirkpatrick; Kimberley S. Mak; Helen A. Shih; Alex Engelman; David Roberge; Nils D. Arvold; Brian Alexander; Mark M. Awad; Joseph Contessa; Veronica Chiang; John Hardie; Daniel Ma; Emil Lou; William Sperduto; Minesh P. Mehta

doi:10.1001/jamaoncol.2016.3834

Estimating Survival in Patients With Lung Cancer and Brain Metastases: An Update of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA).

Paul W. Sperduto, T. Jonathan Yang, Kathryn Beal, Hubert Pan, Paul D. Brown, Ananta Bangdiwala, Ryan Shanley, Norman Yeh, Laurie E. Gaspar, Steve Braunstein, Penny Sneed, John Boyle, John P. Kirkpatrick, Kimberley S. Mak, Helen A. Shih, Alex Engelman, David Roberge, Nils D. Arvold, Brian Alexander, Mark M. AwadJoseph Contessa, Veronica Chiang, John Hardie, Daniel Ma, Emil Lou, William Sperduto, Minesh P. Mehta

Miami Cancer Institute

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	JAMA Oncology
Volume	3
DOIs	https://doi.org/10.1001/jamaoncol.2016.3834
State	Published - Jun 1 2017

Disciplines

Medicine and Health Sciences
Surgery
Oncology
Genetics
Pathology

Access to Document

10.1001/jamaoncol.2016.3834License: Unspecified

Cite this

Sperduto, P. W., Yang, T. J., Beal, K., Pan, H., Brown, P. D., Bangdiwala, A., Shanley, R., Yeh, N., Gaspar, L. E., Braunstein, S., Sneed, P., Boyle, J., Kirkpatrick, J. P., Mak, K. S., Shih, H. A., Engelman, A., Roberge, D., Arvold, N. D., Alexander, B., ... Mehta, M. P. (2017). Estimating Survival in Patients With Lung Cancer and Brain Metastases: An Update of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA). JAMA Oncology, 3. https://doi.org/10.1001/jamaoncol.2016.3834

Sperduto, PW, Yang, TJ, Beal, K, Pan, H, Brown, PD, Bangdiwala, A, Shanley, R, Yeh, N, Gaspar, LE, Braunstein, S, Sneed, P, Boyle, J, Kirkpatrick, JP, Mak, KS, Shih, HA, Engelman, A, Roberge, D, Arvold, ND, Alexander, B, Awad, MM, Contessa, J, Chiang, V, Hardie, J, Ma, D, Lou, E, Sperduto, W & Mehta, MP 2017, 'Estimating Survival in Patients With Lung Cancer and Brain Metastases: An Update of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA).', JAMA Oncology, vol. 3. https://doi.org/10.1001/jamaoncol.2016.3834

@article{539705a50dc64c94a0bd7ddec4caf871,

title = "Estimating Survival in Patients With Lung Cancer and Brain Metastases: An Update of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA).",

author = "Sperduto, {Paul W.} and Yang, {T. Jonathan} and Kathryn Beal and Hubert Pan and Brown, {Paul D.} and Ananta Bangdiwala and Ryan Shanley and Norman Yeh and Gaspar, {Laurie E.} and Steve Braunstein and Penny Sneed and John Boyle and Kirkpatrick, {John P.} and Mak, {Kimberley S.} and Shih, {Helen A.} and Alex Engelman and David Roberge and Arvold, {Nils D.} and Brian Alexander and Awad, {Mark M.} and Joseph Contessa and Veronica Chiang and John Hardie and Daniel Ma and Emil Lou and William Sperduto and Mehta, {Minesh P.}",

note = "Question What is the effect of molecular alterations on survival of patients with non-small-cell lung cancer and brain metastases? In this database analysis, in addition to previously known prognostic factors, Findings EGFR and ALK gene alterations of the original primary lung tumor were found to be associated with survival.",

year = "2017",

month = jun,

day = "1",

doi = "10.1001/jamaoncol.2016.3834",

language = "American English",

volume = "3",

journal = "JAMA Oncology",

}

TY - JOUR

T1 - Estimating Survival in Patients With Lung Cancer and Brain Metastases: An Update of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA).

AU - Sperduto, Paul W.

AU - Yang, T. Jonathan

AU - Beal, Kathryn

AU - Pan, Hubert

AU - Brown, Paul D.

AU - Bangdiwala, Ananta

AU - Shanley, Ryan

AU - Yeh, Norman

AU - Gaspar, Laurie E.

AU - Braunstein, Steve

AU - Sneed, Penny

AU - Boyle, John

AU - Kirkpatrick, John P.

AU - Mak, Kimberley S.

AU - Shih, Helen A.

AU - Engelman, Alex

AU - Roberge, David

AU - Arvold, Nils D.

AU - Alexander, Brian

AU - Awad, Mark M.

AU - Contessa, Joseph

AU - Chiang, Veronica

AU - Hardie, John

AU - Ma, Daniel

AU - Lou, Emil

AU - Sperduto, William

AU - Mehta, Minesh P.

N1 - Question What is the effect of molecular alterations on survival of patients with non-small-cell lung cancer and brain metastases? In this database analysis, in addition to previously known prognostic factors, Findings EGFR and ALK gene alterations of the original primary lung tumor were found to be associated with survival.

PY - 2017/6/1

Y1 - 2017/6/1

UR - https://jamanetwork.com/journals/jamaoncology/fullarticle/2585030

U2 - 10.1001/jamaoncol.2016.3834

DO - 10.1001/jamaoncol.2016.3834

M3 - Article

VL - 3

JO - JAMA Oncology

JF - JAMA Oncology

ER -

Estimating Survival in Patients With Lung Cancer and Brain Metastases: An Update of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA).

Disciplines

Access to Document

Other files and links

Cite this